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Lithium is widely used in psychotherapy. The 6Li isotope has a
long intrinsic longitudinal relaxation time T1 on the order of
minutes, making it an ideal candidate for hyperpolarization ex-
periments. In the present study we demonstrated that lithium-6
can be readily hyperpolarized within 30 min, while retaining a
long polarization decay time on the order of a minute. We used
the intrinsically long relaxation time for the detection of 500 nM
contrast agent in vitro. Hyperpolarized lithium-6 was adminis-
tered to the rat and its signal retained a decay time on the order
of 70 sec in vivo. Localization experiments imply that the lithium
signal originated from within the brain and that it was detect-
able up to 5 min after administration. We conclude that the
detection of submicromolar contrast agents using hyperpolar-
ized NMR nuclei such as 6Li may provide a novel avenue for
molecular imaging. Magn Reson Med 61:1489–1493, 2009.
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In clinical practice, lithium (Li) salts are used for the
treatment of manic-depressive (bipolar) and depressive
disorders (1,2). Once dissolved, lithium does not bind to
any complexes and remains in its cationic form. It natu-
rally exists as a mixture of two stable isotopes (3): lithi-
um-6 (7.42%) and lithium-7 (92.58%). Because of its
higher natural abundance, shorter relaxation times, and
higher relative sensitivity, 7Li NMR has been established
as a noninvasive tool to study lithium pharmacokinetics
and distribution in vivo (4,5). Given the interest in psychi-
atric treatment, most studies have focused on the brain.
The isotope 6Li has a long longitudinal relaxation time T1
as well as a low gyromagnetic ratio and natural abundance,
yielding a disadvantageously low sensitivity; hence, virtually
no in vivo studies using 6Li NMR have to date been reported.
However, the long T1 of 170 sec in H2O at room temperature
(6) and 1040 sec in D2O at 80°C (7) makes it a suitable
candidate for hyperpolarization experiments.
Dynamic nuclear polarization (DNP) (8) has recently
found renewed interest in the ﬁeld of medical NMR and
MRI due to the rapid dissolution from a solid-state polar-
ized sample in the polarizer to a room-temperature inject-
able solution (9). Dissolution DNP has been reported to
enhance the polarization (and thus signal strength) of nu-
clei such as 13C by several orders of magnitude; however,
once the sample is taken out of the polarizer this large
polarization relaxes with the nuclei’s intrinsic longitudi-
nal relaxation time (T1). Given the limited time that the
signal ampliﬁcation is available, research using dissolu-
tion DNP has been limited to nuclei with long T1, primar-
ily the 13C nuclei in carboxyl groups (-COOH) with T1 on
the order of 20–60 sec, such as pyruvate (10), acetate (11),
and bicarbonate (12).
While much of the research has focused on 13C and its
potential for metabolic studies, we have recently proposed
that hyperpolarization NMR could be used for the detec-
tion of small concentrations of contrast agents (13). Be-
cause 6Li has an intrinsic T1 that is several-fold longer than
that of most 13C nuclei, it could potentially provide en-
hanced signal much longer. This longer lasting of its signal
can be combined with the principle that the relative effect
of a contrast agent on a medium becomes more pro-
nounced if the signal relaxes over a longer time. We have
recently predicted that detection of contrast agent concen-
trations in the nanomolar range should be feasible, allow-
ing novel avenues in molecular imaging.
Therefore, the aim of the present study was 3-fold: ﬁrst,
to establish the feasibility of dissolution DNP of 6Li and to
study the relaxation behavior of hyperpolarized 6Li in the
spectrometer. Second, to demonstrate that hyperpolarized
6Li can detect contrast agent in the submicromolar concen-
tration range. Third, to detect hyperpolarized 6Li in the rat
brain in vivo.
MATERIALS AND METHODS
For the hyperpolarization of 6Li, a 15 M 95% isotopically
enriched lithium-6 chloride (Icon Isotopes, Summit, NJ) in
33/67 vol% ethanol-d6/D2O (Cambridge Isotope Laborato-
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ries, Andover, MA) solution was prepared. 300 L (phan-
tom) or 40 L (in vivo) of this solution was frozen in liquid
nitrogen as beads. 33 mM of TEMPO (2,2,6,6-tetramethyl-
1-piperidinyloxy, 98% purity, Sigma-Aldrich, St. Louis,
MO) was added as polarizing agent. DNP of this sample
and dissolution into 5 mL D2O was performed in a custom-
built 3.35 T polarizer as previously described (11,14).
Brieﬂy, after microwave irradiation at 94 GHz (3.35 T) and
T  1.2 K, superheated (180°C) high-pressure (12 bar)
D2O was blown over the sample into a combined phase
separator and infusion pump placed in the bore of the 9.4
T/31 cm magnet with 12 cm i.d. high-performance gradi-
ents (400 mT/m in 130 s, Varian, Palo Alto, CA), posi-
tioned 4 m from the DNP polarizer. 2.5 mL of the sample
with a ﬁnal 6Li concentration of 900 mM (phantom) or
120 mM (in vivo) was then injected from the separator/
infusion pump using a remote injection pump within 9
sec.
Signal acquisition typically started 18 sec after dissolu-
tion. A custom-built 4-loop 8 mm diameter surface coil
was used for 6Li excitation and detection, with quadrature
14 mm 1H coils used for localized MRI and shimming with
FASTMAP (15).
Lithium-6 has the potential to detect low concentrations
of contrast agents as follows: since hyperpolarized media
have a nonregenerating initial longitudinal magnetization
that will decay with an intrinsic decay time , a contrast
agent will affect this magnetization with its longitudinal
relaxivity r1 (in mM1s1), with an observed decay time
obs expressed as 1/obs  1/r1[CA], where [CA] is the
contrast agent concentration. As a consequence, while a
contrast agent may not have generated much contrast be-
tween a compartment with it and one without it 1 sec after
a ﬁrst excitation (and acquisition), 10 sec later the differ-
ence in  between the compartments may generate signif-
icant signal difference. More formally, if the signal S of a
hyperpolarized medium at a time t after dissolution is
described by S  S0et/, where S0 is the starting signal,
then the contrast C  SA/SB between two compartments A
and B with the same starting signal can be expressed as:
C 
et/obs
et/

etCAr1t/
et/
 etCAr1. [1]
As a demonstration, let us take for example a contrast
agent with r1  5 mM1s1 at a concentration of 500 nM,
and wait t  100 sec, which should be feasible given the
relaxation times of 6Li. The contrast generated after 100 sec
according to Eq. [1] would be C 0.78, which, given a high
enough signal-to-noise ratio (SNR), should easily be dis-
cernible by NMR. Gd-DOTP had previously been shown to
have a relaxivity r1  11 mM1s1 for 6Li (13), which
should create a notable effect on the lithium signal decay
over 100 sec even when applied at concentrations below
1 M.
To test the ability to detect such low concentrations of
Gd-DOTP, a phantom consisting of a block of Ertacetal (a
magnetically neutral plastic, AngstPﬁster, Switzerland)
with two 1 	 1 cm2 holes with a 0.5 mm thick bottom,
separated by a 2 mm thick wall was used (n  2 experi-
ments). The RF coil was placed directly under the separa-
tion wall. Both holes were ﬁlled with 1.5 mL D2O, while
one of them was doped with 500 nM Gd-DOTP (16)
(Gd(III)-(1,4,7,10-tetraazacyclododecane-1,4,7,10-tetra(m-
ethylenephosphonate)), Macrocyclics, Dallas, TX). The
signal of the two compartments was measured with 120
separately stored repetitions of a gradient-recalled se-
quence (3 ms 10° BIR-4 pulse, TR  5 sec), resulting after
fast Fourier transform (FFT) in 1D projections that con-
sisted of 32 points (TE  1043 s). These projections were
then zero-ﬁlled to 256 points, and the integral of the signal
of each compartment was calculated. Curve ﬁtting was
done from t  30 to 300 sec in OriginPro (OriginLab,
Northampton, MA) using an exponential decay function.
In vivo experiments were performed on male Spra-
gue–Dawley rats (400 g, Charles River Laboratories,
France). All experiments were approved by the local
ethics committee. Animals were anesthetized with 1.5%
isoﬂurane in a 30% O2/70% N2O mixture and a femoral
vein was catheterized for infusion of lithium. The rat
was then inserted in the scanner, where physiology was
monitored and kept stable: body temperature was kept at
37.3 
 0.5°C, while the respiration rate was maintained
at 60 min1 by adjustment of the isoﬂurane dose. Since
the injected volume of 2.5 mL had an estimated lithium
concentration of 120 mM, the dilution in an estimated
blood volume of 30 mL resulted in a ﬁnal blood concen-
tration of LiCl in animals of 10 mM; above the chronic
therapeutic dose of 0.6–1.2 mM (2), but still almost an
order of magnitude below the acute LD50 of 75 mM
(calculated from Ref. (17)).
The relaxation constant  was determined (n  5 exper-
iments) from the signal decay measured with a 10° BIR-4
pulse (18) applied every 3 sec over 600 sec. Following 5 Hz
line broadening, the peak area was determined and the nth
excitation was corrected for the magnetization decrease
due to the previous repetitive excitations by dividing by
cos(10°)n1. This correction did not account for in-ﬂow
into the sensitive volume, and as such provides an upper
estimate of the in vivo relaxation time.
The 6Li distribution was imaged in four experiments
with a gradient echo sequence (2 ms sinc pulse) with an
echo time of 2 ms and a repetition time of 100 ms: a total
of 32 sequential images were thus acquired in 51.2 sec The
matrix size was 16 	 16 with a ﬁeld of view of 6 	 6 cm2
and a single slice of 1 cm thickness. Prior to FFT, images
were zero-ﬁlled to 128 	 128 and corrected for DC offset.
Three 10° BIR-4 pulse-acquire experiments preceded the
imaging to estimate the relative signal strength and decay
of the hyperpolarized 6Li, thus the imaging started 25 sec
after dissolution.
In two experiments localized spectroscopy was per-
formed every 60 sec with outer volume suppression in
three dimensions. A 6 	 8 	 10 mm3 voxel was placed in
the top of the rat brain, as close to the detection coil as
possible. A 45° BIR-4 pulse was used for excitation, while
three pairs of hyperbolic secant pulses performed the outer
volume suppression. Due to the longer time between
pulses, no correction for the ﬂip angle was made in this
case, resulting in the technique providing a lowest esti-
mate of the in vivo relaxation time.
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RESULTS
In the polarizer, the lithium-6 chloride sample polarized
with a time constant of 450 sec, while the enhancement
factor at 1.2 K in the 3.35 T cryostat was 135, equivalent
to 7% total polarization or an 12,000-fold enhance-
ment compared to room temperature polarization at 9.4 T.
The sample was dissolved and transferred to the spectrom-
eter in 6 sec.
We had previously proposed that 6Li relaxation may be
exquisitely sensitive to certain negatively charged contrast
agents (13). We therefore sought to demonstrate the prin-
ciple in a two-compartment phantom experiment. These
experiments (n  2) displayed the expected effect of the
contrast agent (Fig. 1): the signal in the contrast agent-
doped compartment decayed faster than that of the other
compartment. The decay time pure of the compartment
without the contrast agent was 180
 12 s (and R2 0.986),
while that of the compartment containing the contrast
agent was CA  100 
 4 sec (and R2  0.995). From the
expression for relaxivity (1/CA 1/ pure [CA] r1, see Eq.
[1]) with r1  11 mM1s1; this resulted in [CA]  440 nM,
consistent with the estimated concentration of 500 nM.
Conversely, taking the signal difference 100 sec after nor-
malizing the two decay curves and using Eq. [1], the cal-
culated contrast agent concentration was 400 
 20 nM.
In the in vivo pulse-acquire experiments (n  5) the
relaxation displayed an exponential decay with a decay
time of   72 
 5 sec (Fig. 2). The signal remained
observable for over 3 min (Fig. 2a), despite repeated RF
pulsing. The SNR was10-fold lower than in the phantom
experiments, ascribed to as both a lower polarized sample
volume and a lower average ﬁnal concentration.
All four 6Li imaging experiments show a distribution of
lithium signal with a maximum in the brain (Fig. 3). Prior
to zero-ﬁlling the four high-intensity voxels were located
inside the brain. Image intensity persisted through multi-
ple images, with a  in the same range as the pulse-acquire
experiments described above.
In two studies we measured the in vivo 6Li signal using
localized spectroscopy to establish its presence in the
brain (Fig. 4). The signal was still detected 5.5 min after
dissolution, conﬁrming a similar decay constant as the
pulse-acquire studies (bottom trace in Fig. 4).
DISCUSSION
The present study shows for the ﬁrst time that lithium-6
can be readily hyperpolarized via dissolution DNP to a
total polarization of 7% in 30 min. We furthermore dem-
onstrated a unique sensitivity to contrast agents in the
submicromolar range and the injection and detection of
hyperpolarized 6Li in the live rat brain.
The polarization decay appeared to be inﬂuenced by the
presence of the TEMPO radical, which itself acts as a
FIG. 1. Decay curves of a two-compartment phantom. Both curves
were normalized to their ﬁrst point. The compartment without con-
trast agent (upper curve) had a relaxation time of 181 
 8 sec, while
the compartment with contrast agent decayed with T  99 
 2 sec.
FIG. 2. a: Series of spectra of hyperpolarized lithium in the rat brain.
Individual spectra were processed with 5 Hz line broadening. Signal
is visible up to 300 sec after dissolution. b: Integrals of the same
peaks in the rat head, corrected for the ﬂip angle of the excitation
pulse. The solid line is an exponential ﬁt with a decay time of 72 

5 sec.
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contrast agent. The more diluted in D2O the sample is (and
thus the lower the 6Li and TEMPO concentrations), the
longer its T1: 1040 sec in pure D2O and 179 sec in the
two-compartment phantom (i.e., D2O with TEMPO).
To test whether 6Li can detect contrast agents in the
submicromolar range we demonstrated the effect of 500
nM Gd-DOTP. The detection limit, however, can be low-
ered substantially compared to what we demonstrated in
this study: assume for example that sensitivity is such
that 10% signal difference due to Gd-DOTP can be de-
tected, which is equivalent to setting C  0.9 in Eq. [1].
The consequent calculation results in a detectable con-
trast agent concentration [CA] of 10 nM after 100 sec,
and 5 nM after 200 sec. We noted that the 6Li signal was
still detected 200 sec after dissolution even in the pres-
ence of 500 nM GdDOTP. Designing even more powerful
contrast agents is likely to push the detection limit into
the picomolar range, which opens novel perspectives for
molecular imaging.
Our studies, both by imaging and localized spectros-
copy, suggest a localization of 6Li to the brain. However, it
is in principle possible that the signal remained conﬁned
to the vascular compartment. The images, however, sug-
gest a predominantly cerebral localization of 6Li, in par-
ticular considering that the maximum signal does not co-
localize with major blood vessels. Although lithium up-
take into the brain is considered slow, it is of interest to
note that all studies measuring lithium uptake show a
sizeable fraction of their maximum lithium signal in the
ﬁrst measurement within minutes (5,19,20). Our present
study suggests that a sufﬁcient fraction of lithium enters
the brain over the time of 6Li hyperpolarization, i.e.,
3–5 min. It is in principle possible to enhance the transient
uptake of lithium in the brain by transiently opening the
blood–brain barrier using, e.g., mannitol. In a parallel
manner, hyperpolarized 6Li might be applied to detect
cerebral tumors that disrupt the blood–brain barrier.
CONCLUSIONS
We conclude that 6Li can 1) be hyperpolarized, 2) that it
can be used to detect very low contrast agent concentra-
tions, and 3) that it can be administered in vivo, upon
which it enters the brain in sufﬁcient concentrations to be
detected with localized spectroscopy.
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